The other authors declared no competing interests. Eosinophilic esophagitis is a clinicopathological disease characterized by a wide variety of GERD-like symptoms, dysphagia and vomiting that ...

Eosinophilic esophagitis (EoE) is a chronic esophageal inflammatory disease of undetermined pathophysiology that results in dense mucosal eosinophilia and esophageal dysfunction. In childhood ...

First identified in 1989, eosinophilia-myalgia syndrome is a rare condition that produces inflammation in the muscles, lungs, and skin. Patients with this syndrome also have elevated levels of ...

Physician researchers at Phoenix Children's have pioneered the use of the esophageal string test (EST), a minimally invasive ...

Patients with eosinophilic asthma tend to have more severe disease, and more frequent asthma exacerbations. In the past five years, three monoclonal antibody therapies that target interleukin-5 or ...

Researchers at the, Riverside, backed by a substantial NIH grant, are pioneering a study on the unique immune responses to ...

Eosinophilic angiocentric fibrosis (EAF ... particularly IgG4-related disease (IgG4-RD), as well as to better understand its clinical manifestations and treatment options. One of the key studies ...

Of four treatment response measures recorded at 6 months of mepolizumab treatment, an Asthma Control Questionnaire score was ...

“The global prevalence of eosinophilic esophagitis has more than doubled over the prior decade, leading to a significant burden of disease,” said Evan S. Dellon, M.D., MPH, Professor of ...

According to the Centers for Disease Control and Prevention, more than two in five American adults have obesity, a common and ...

EMA accepts for review GSK’s MAA for depemokimab for use in asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 09:00 Hrs [IST] GSK plc announced ...